12 blockbuster drugs owned by ‘big three’

Published: 2012-04-09 06:58:00

Updated: 2012-04-09 06:58:00

Korea’s so-called ‘big three’ drug makers - Dong-A Pharmaceutical, Daewoong Pharmaceutical and Yuhan Corp. - released 12 blockbuster drugs generating more than 30 billion won of revenue for their owner last year.

A report from Yakup.com., a pharmaceutical information company, said that the top...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK